Kane Biotech (TSXV:KNE) 3-Year EBITDA Growth Rate : 11.00% (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Kane Biotech 3-Year EBITDA Growth Rate?

Kane Biotech's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 11.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kane Biotech was 47.70% per year. The lowest was -38.70% per year. And the median was 10.75% per year.

Competitive Comparison of Kane Biotech's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Kane Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kane Biotech's 3-Year EBITDA Growth Rate falls into.

Kane Biotech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kane Biotech (TSXV:KNE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kane Biotech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kane Biotech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech (TSXV:KNE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (TSXV:KNE) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

KNBIF:USA

Address

290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2

Website

https://www.kanebiotech.com

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.

Executives

Philip Renaud

Director

Kane Biotech (TSXV:KNE) Headlines

No Headlines